| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |